Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma

Abstract

We conducted a genome-wide scan of SNPs to identify variants associated with length of survival in 1,331 individuals with esophageal squamous-cell carcinoma (ESCC), with associations validated in 2 independent sets including 1,962 individuals with this cancer. We identified rs1050631 in SLC39A6 as associated with the survival times of affected individuals, with the hazard ratio for death from ESCC in the combined sample being 1.30 (95% confidence interval (CI) = 1.19−1.43; P = 3.77 × 10−8). rs7242481, located in the 5′ UTR of SLC39A6, disturbs a transcriptional repressor binding site and results in upregulation of SLC39A6 expression. Immunohistochemical staining of ESCC tissues showed that higher expression of SLC39A6 protein was correlated with shorter length of survival in individuals with advanced ESCC (P = 0.013). Knockdown of SLC39A6 expression suppressed proliferation and invasion in ESCC cells. These results suggest that SLC39A6 has an important role in the prognosis of ESCC and may be a potential therapeutic target.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Kaplan-Meier estimates of survival time for individuals with ESCC stratified by SLC39A6 genotype.
Figure 2: Functional characterization of the rs7242481 SNP.
Figure 3: Expression of SLC39A6 in human ESCC cell lines and clinical specimens.
Figure 4: Effects of SLC39A6 knockdown on ESCC cell proliferation, migration and invasion.

Similar content being viewed by others

References

  1. Zhao, P., Dai, M., Chen, W. & Li, N. Cancer trends in China. Jpn. J. Clin. Oncol. 40, 281–285 (2010).

    Google Scholar 

  2. Zhang, D.W. et al. Operable squamous esophageal carcinoma: current results from the East. World J. Surg. 18, 347–354 (1994).

    Article  CAS  Google Scholar 

  3. Wang, L.S. et al. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors. Am. J. Gastroenterol. 94, 1933–1940 (1999).

    Article  CAS  Google Scholar 

  4. Liu, J. et al. Which factors are associated with actual 5-year survival of oesophageal squamous cell carcinoma? Eur. J. Cardiothorac. Surg. 41, e7–e11 (2012).

    Article  Google Scholar 

  5. Lee, P.C., Port, J.L., Paul, S., Stiles, B.M. & Altorki, N.K. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases. Ann. Thorac. Surg. 88, 186–192 (2009).

    Article  Google Scholar 

  6. Sun, Z.G. & Wang, Z. Clinical study on lymph node metastatic recurrence in patients with N0 esophageal squamous cell cancer. Dis. Esophagus 24, 182–188 (2011).

    Article  Google Scholar 

  7. Okumura, H. et al. Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy. Int. J. Clin. Oncol. 18, 329–334 (2013).

    Article  CAS  Google Scholar 

  8. Stiles, B.M. et al. Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer. J. Thorac. Cardiovasc. Surg. 139, 387–394 (2010).

    Article  Google Scholar 

  9. Thrift, A.P. et al. The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival. Int. J. Cancer 130, 2407–2416 (2012).

    Article  CAS  Google Scholar 

  10. Azzato, E.M. et al. Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor–negative breast cancer survival. J. Natl. Cancer Inst. 102, 650–662 (2010).

    Article  CAS  Google Scholar 

  11. Wu, C. et al. Genome-wide interrogation identifies YAP1 variants associated with survival of small-cell lung cancer patients. Cancer Res. 70, 9721–9729 (2010).

    Article  CAS  Google Scholar 

  12. Wu, X. et al. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. J. Natl. Cancer Inst. 103, 817–825 (2011).

    Article  CAS  Google Scholar 

  13. Lu, C., Xie, H., Wang, F., Shen, H. & Wang, J. Diet folate, DNA methylation and genetic polymorphisms of MTHFR C677T in association with the prognosis of esophageal squamous cell carcinoma. BMC Cancer 11, 91 (2011).

    Article  CAS  Google Scholar 

  14. Boonstra, J.J., van Marion, R., Tilanus, H.W. & Dinjens, W.N. Functional polymorphisms associated with disease-free survival in resected carcinoma of the esophagus. J. Gastrointest. Surg. 15, 48–56 (2011).

    Article  Google Scholar 

  15. Kuwahara, A. et al. TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma. J. Exp. Clin. Cancer Res. 29, 100 (2010).

    Article  Google Scholar 

  16. Okuno, T. et al. Favorable genetic polymorphisms predictive of clinical outcome of chemoradiotherapy for stage II/III esophageal squamous cell carcinoma in Japanese. Am. J. Clin. Oncol. 30, 252–257 (2007).

    Article  CAS  Google Scholar 

  17. Kaneko, K. et al. EGFR gene alterations as a prognostic biomarker in advanced esophageal squamous cell carcinoma. Front. Biosci. 15, 65–72 (2010).

    Article  CAS  Google Scholar 

  18. Innocenti, F. et al. A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303. Clin. Cancer Res. 18, 577–584 (2012).

    Article  CAS  Google Scholar 

  19. Willis, J.A. et al. A replication study and genome-wide scan of single nucleotide polymorphisms associated with pancreatic cancer risk and overall survival. Clin. Cancer Res. 18, 3942–3951 (2012).

    Article  CAS  Google Scholar 

  20. Wu, C. et al. Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Gut published online; doi:10.1136/gutjnl-2012-303477 (24 November 2012).

  21. Shu, X.O. et al. Novel genetic markers of breast cancer survival identified by a genome-wide association study. Cancer Res. 72, 1182–1189 (2012).

    Article  CAS  Google Scholar 

  22. Cui, R. et al. Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology 137, 1768–1775 (2009).

    Article  CAS  Google Scholar 

  23. Wang, L.D. et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat. Genet. 42, 759–763 (2010).

    Article  CAS  Google Scholar 

  24. Abnet, C.C. et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat. Genet. 42, 764–767 (2010).

    Article  CAS  Google Scholar 

  25. Wu, C. et al. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat. Genet. 43, 679–684 (2011).

    Article  CAS  Google Scholar 

  26. Taylor, K.M. & Nicholson, R.I. The LZT proteins; the LIV-1 subfamily of zinc transporters. Biochim. Biophys. Acta 1611, 16–30 (2003).

    Article  CAS  Google Scholar 

  27. John, E. et al. Zinc in innate and adaptive tumor immunity. J. Transl. Med. 8, 118 (2010).

    Article  Google Scholar 

  28. Ma, X. et al. Identification of LIV1, a putative zinc transporter gene responsible for HDACi-induced apoptosis, using a functional gene screen approach. Mol. Cancer Ther. 8, 3108–3116 (2009).

    Article  CAS  Google Scholar 

  29. Yamashita, S. et al. Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer. Nature 429, 298–302 (2004).

    Article  CAS  Google Scholar 

  30. Zhao, L., Chen, W., Taylor, K.M., Cai, B. & Li, X. LIV-1 suppression inhibits HeLa cell invasion by targeting ERK1/2-Snail/Slug pathway. Biochem. Biophys. Res. Commun. 363, 82–88 (2007).

    Article  CAS  Google Scholar 

  31. Unno, J. et al. LIV-1 enhances the aggressive phenotype through the induction of epithelial to mesenchymal transition in human pancreatic carcinoma cells. Int. J. Oncol. 35, 813–821 (2009).

    CAS  PubMed  Google Scholar 

  32. Lue, H.W. et al. LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling. PLoS ONE 6, e27720 (2011).

    Article  CAS  Google Scholar 

  33. Lopez, V. & Kelleher, S.L. Zip6-attenuation promotes epithelial-to-mesenchymal transition in ductal breast tumor (T47D) cells. Exp. Cell Res. 316, 366–375 (2010).

    Article  CAS  Google Scholar 

  34. Thiery, J.P. Epithelial-mesenchymal transition in tumour progression. Nat. Rev. Cancer 2, 447–454 (2002).

    Article  Google Scholar 

  35. Jing, Y., Han, Z., Zhang, S., Liu, Y. & Wei, L. Epithelial-mesenchymal transition in tumor microenvironment. Cell Biosci. 1, 29 (2011).

    Article  CAS  Google Scholar 

  36. Radisky, D.C. & LaBarge, M.A. Epithelial-mesenchymal transition and the stem cell phenotype. Cell Stem Cell 2, 511–512 (2008).

    Article  CAS  Google Scholar 

  37. Taylor, K.M., Hiscox, S. & Nicholson, R.I. Zinc transporter LIV-1: a link between cellular development and cancer progression. Trends Endocrinol. Metab. 15, 461–463 (2004).

    Article  CAS  Google Scholar 

  38. Sauna, Z.E. & Kimchi-Sarfaty, C. Understanding the contribution of synonymous mutations to human disease. Nat. Rev. Genet. 12, 683–691 (2011).

    Article  CAS  Google Scholar 

  39. Kimchi-Sarfaty, C. et al. A “silent” polymorphism in the MDR1 gene changes substrate specificity. Science 315, 525–528 (2007).

    Article  CAS  Google Scholar 

  40. Chen, R., Davydov, E.V., Sirota, M. & Butte, A.J. Non-synonymous and synonymous coding SNPs show similar likelihood and effect size of human disease association. PLoS ONE 5, e13574 (2010).

    Article  Google Scholar 

  41. Wigginiton, J.E., Cutler, D.J. & Abecasis, G.R. A note on exact tests of Hardy-Weinberg equilibrium. Am. J. Hum. Genet. 76, 887–893 (2005).

    Article  Google Scholar 

  42. Lehmann, U. & Kreipe, H. Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies. Methods 25, 409–418 (2001).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We acknowledge Y. Shimada (Hyogo College of Medicine) for providing the eight ESCC cell lines. This work was funded by the National Basic Research Program of China (2013CB910303 and 2011CB504303) and the National Natural Science Foundation of China (91229126).

Author information

Authors and Affiliations

Authors

Contributions

Dongxin Lin was the overall principal investigator of the study who conceived the study, obtained financial support, was responsible for study design, oversaw the entire study, interpreted the results, and wrote parts of and synthesized the manuscript. C.W. performed overall project management, oversaw laboratory analyses, performed statistical analyses and drafted the initial version of the manuscript. D. Li, Y.Q., Yuling Zhou, J.C., K.Z. and Menghan Wang performed functional analyses. W.J. and Y. Zeng were responsible for subject recruitment and sample preparation for Guangzhou samples. Z.H., Yifeng Zhou and H.S. were responsible for subject recruitment and sample preparation for Jiangsu samples. D.Y. and W.T. performed subject recruitment and sample preparation for Beijing samples. T.T. and Mingrong Wang were responsible for subject recruitment and preparation of ESCC tissue microarrays. Dongmei Lin and L.W. were responsible for the IHC analysis of tissue microarrays.

Corresponding author

Correspondence to Dongxin Lin.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Tables 1 and 3, Supplementary Figures 1–6 (PDF 1212 kb)

Supplementary Table 2

Associations of SNPs in SLC39A6 region with hazard risk of death of ESCC patients in the discovery sample (XLSX 13 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wu, C., Li, D., Jia, W. et al. Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma. Nat Genet 45, 632–638 (2013). https://doi.org/10.1038/ng.2638

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.2638

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing